Single Cell Genomics of Psoriatic Skin
NCT02929745 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 16
Last updated 2021-09-23
Summary
The purpose of this study is to understand how genetics play a role in psoriasis. Specifically, a genetic allele HLA-Cw6 is known to be associated with psoriasis, and this study aims to find out how it affects genetic and protein expression in patients with psoriasis, compared to healthy people, at a single-cell level using a novel flow cytometry and RNA-sequencing protocol.
Conditions
Interventions
- PROCEDURE
-
Skin biopsy
Four 4-5 mm punch biopsies of the skin
- PROCEDURE
-
Blood draw
Blood will be drawn to test for HLA-cw6 status
Sponsors & Collaborators
-
Janssen Pharmaceuticals
collaborator INDUSTRY -
University of California, San Francisco
lead OTHER
Principal Investigators
-
Wilson Liao, MD · University of California, San Francisco
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- BASIC_SCIENCE
- Masking
- NONE
- Model
- FACTORIAL
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- Yes
Timeline & Regulatory
- Start
- 2016-07-01
- Primary Completion
- 2020-12-09
- Completion
- 2020-12-09
Countries
- United States
Study Locations
More Related Trials
-
An Observational Study to Evaluate Patient-Reported Experiences of Living With Moderate-to-Severe Plaque Psoriasis
NCT01555606 ·Status: COMPLETED
-
IL-17 Role in Variants of Psoriasis
NCT02078297 ·Status: COMPLETED
-
Phase 1 Study of CC-90005 in Healthy Subjects and Subjects With Moderate to Severe Plaque-type Psoriasis
NCT02502188 ·Status: TERMINATED ·Phase: PHASE1
-
Role of Chemokine and Chemokine Receptor in Psoriasis
NCT03302390 ·Status: WITHDRAWN
-
Correction of Psoriatic T Cell Signatures by Deucravacitinib
NCT05858645 ·Status: RECRUITING ·Phase: PHASE4
-
An Efficacy and Safety Study of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
NCT02326298 ·Status: COMPLETED ·Phase: PHASE3
-
Multiple Dose Escalation Study In Medically Stable Subjects With Psoriasis
NCT01736696 ·Status: COMPLETED ·Phase: PHASE1
-
Regulation of Inflammatory Genes in Psoriasis
NCT03125655 ·Status: RECRUITING
-
The Association Between Psoriasis and Intestinal Bacterial Population
NCT02417792 ·Status: COMPLETED
-
A Study to Evaluate the Efficacy and Safety of Two Dose Levels of Certolizumab Pegol (CZP) in Subjects With Plaque Psoriasis (PSO)
NCT02326272 ·Status: COMPLETED ·Phase: PHASE3
-
Exploratory Evaluation of Biomarkers Associated With Treatment Response to Cosentyx (Secukinumab) in Psoriasis Patients
NCT03149900 ·Status: COMPLETED
-
Study to Evaluate the Safety, Tolerability, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of CC-90006 in Subjects With Mild to Moderate Plaque-type Psoriasis
NCT03337022 ·Status: COMPLETED ·Phase: PHASE1
-
Cytokine Expression in Psoriasis Patients with and Without Joint Involvement
NCT05307809 ·Status: RECRUITING ·Phase: NA
-
Study of MEDI-522 Administered by Subcutaneous Injection to Adults With Plaque Psoriasis
NCT00192517 ·Status: COMPLETED ·Phase: PHASE2
-
A Study to Determine the Optimal Dose of Tildrakizumab (SCH 900222/MK-3222) for the Treatment of Moderate-to-severe Chronic Plaque Psoriasis (P05495) (MK-3222-003)
NCT01225731 ·Status: COMPLETED ·Phase: PHASE2
-
A Study of Zasocitinib in Adults With Psoriatic Arthritis Who Have or Have Not Been Treated With Biologic Medicines
NCT06671496 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Effect of Bimekizumab on Gene Expression Biomarkers in Study Participants With Moderate to Severe Plaque Psoriasis
NCT06506916 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE3
-
Genomic Study for the Prediction of Efficacy and Adverse Effects of CD11a Monoclonal Antibodies(Raptiva)
NCT00602823 ·Status: COMPLETED
-
A Study to Evaluate Clear Skin Effect on Quality of Life in Patients With Plaque Psoriasis.
NCT02752776 ·Status: COMPLETED ·Phase: PHASE4
-
A Long-term Extension Study of JNJ-77242113 in Participants With Moderate-to-Severe Plaque Psoriasis
NCT05364554 ·Status: COMPLETED ·Phase: PHASE2
-
Analysis of Non-Invasively Collected Microneedle Device Samples From Mild Plaque Psoriasis for Use in Transcriptomics Profiling
NCT03795402 ·Status: COMPLETED
-
A Study of JNJ-77242113 for the Treatment of Moderate-to-Severe Plaque Psoriasis
NCT05357755 ·Status: COMPLETED ·Phase: PHASE2
-
A 24-week, Multicenter, proSpective stUdy to Evaluate the PASI 90 Clinical Response Rate and the Safety PRofile of sEcukinuMab 300 mg in Cw6-negativE and Cw6-positive Patients With Moderate to Severe Chronic Plaque-type Psoriasis (SUPREME)
NCT02394561 ·Status: COMPLETED ·Phase: PHASE3
-
A Long Term Study To Evaluate The Safety, Tolerability And Efficacy Of CP-690,550 In Patients With Moderate To Severe Plaque Psoriasis And/Or Psoriatic Arthritis
NCT01519089 ·Status: COMPLETED ·Phase: PHASE3
-
miRNAs and mRNAs in Psoriasis
NCT01604902 ·Status: UNKNOWN